AMENDED AND RESTATED SECURITY AGREEMENTSecurity Agreement • December 4th, 2007 • Advanced Viral Research Corp • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED SECURITY AGREEMENT (the “Agreement”), is entered into and made effective as of December 3, 2007, by and between ADVANCED VIRAL RESEARCH CORP., a Delaware corporation with its principal place of business located at 200 Corporate Boulevard South, Yonkers, New York 10701 (the “Parent”), and the each subsidiary of the Parent listed on Schedule I attached hereto (each a “Subsidiary,” and collectively and together with the Parent, the “Company”), in favor of the BUYER(S) (the “Secured Party”) listed on Schedule I attached to the Securities Purchase Agreement (the “Securities Purchase Agreement”) dated January 1, 2007 between the Company and the Secured Party.
EMPLOYMENT AGREEMENTEmployment Agreement • December 4th, 2007 • Advanced Viral Research Corp • Pharmaceutical preparations • New York
THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and entered as of December 3, 2007 between Advanced Viral Research Corp., a Delaware corporation (“Employer”), and Dallas E. Hughes, an individual (“Employee”).
PATENT SECURITY AGREEMENTPatent Security Agreement • December 4th, 2007 • Advanced Viral Research Corp • Pharmaceutical preparations
THIS PATENT SECURITY AGREEMENT (“Security Agreement”), dated as of December ___, 2007, between Advanced Viral Research Corp., a Delaware corporation (the “Parent”), Triad Biotherapeutics, Inc., incorporated and existing under the laws of the Delaware (the “Subsidiary”) (collectively the Parent and the Subsidiary are referred to as the “Grantors”) and YA Global Investments, L.P., a Cayman Island exempted limited partnership (the “Lender”).
Asset Purchase Agreement By and Among Advanced Viral Research Corp., Triad Biotherapeutics, Inc. and Vincent P. Gullo and Dallas E. Hughes Dated as of December 3 , 2007Asset Purchase Agreement • December 4th, 2007 • Advanced Viral Research Corp • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT is made and entered into this 3rd day of December 2007, by and among Advanced Viral Research Corp., a Delaware corporation (“Parent”), Triad Biotherapeutics, Inc., a Delaware corporation and wholly owned subsidiary of Parent (the “Purchaser”) and Dallas E. Hughes (“Hughes”) and Vincent P. Gullo (“Gullo”), both individuals (Hughes and Gullo are sometimes referred to individually as a “Seller” and collectively as the “Sellers”). Sellers, Purchaser and Parent are sometimes referred to individually as a “Party” and collectively as the “Parties.” Other capitalized terms used in this Agreement are defined on Appendix A hereto.
